Biomatics Management Company, LLC

Institutional venture firmSEC venture capital fund adviser· Seattle, WashingtonBIOMATICSCAPITAL.COM

Biomatics Capital is a for-profit venture firm investing in transformational data enabled innovation at the intersection of health care and technology.

In the firm's own words, from its website.

Reported fund assets
$209M
sum of its funds' Form ADV filings, last 30 months
Investment team
2
Latest vintage
2019
Contact decision makers
More
Ask DFX about thisView relationshipsFind contactsFundsInvestmentsTeam (2)
As of · the latest observation of this organization; filed figures are as of its latest Form ADV

3 verified contacts (2 firm phone, 1 general firm email)

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Nothing material in the last 180 days.

People to know

View all people

Relationship network

4 connected entities

From financing rounds and every investor named in them, Form ADV and Form D filings, the firm's funds and team, and disclosed LP commitments in the venture capital graph. A round's amount is the size of the round, not money that moved between two investors.

Biomatics Management Company, LLC
Seattle, WA
Reading the network
  • Fund or vehicle
  • Person
›How strength and recency are read

Co-investors are read from the rounds: three or more shared rounds is a strong observed relationship, two a repeat co-investor, one a single round. Funds and people are structural. Nothing is scored that a reader cannot check.

Darker lines were active in the last 24 months or are current; lighter lines are older or undated.

How am I connected?

Name your firm, a company or a person, and DFX finds the published routes to Biomatics Management Company, LLC: a shared portfolio company or board, a prior employer, a co-investor, a shared LP or service provider. Every step is a filed or published record with its source; none is a guess about who knows whom.

See how you connect to Biomatics Management Company, LLC

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Investing

0 companies on record, 0 new in 12 months

Investments on record

0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.

Stated thesis versus observed behaviour

no observed deals yet
Stated (the firm’s website)
Sectors
healthcare, biotech, medtech
Stages
not stated or not yet read
Geography
not stated
Check size
not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate no observed dealsfollow-on rate no observed dealsnew companies, 12 months 0

Team

2 current, 0 departed

Decision makers

who to call first, and why; then everyone else by function

Ranked by the role the firm or its filing states, a route on file and deals led. Every reason is read from the record, never inferred. Routes are published by the person or the firm (their bio, the team page or a filing) and are revealed on a plan; data bought from a provider is never shown, and a route printed at a firm the person has since left is held back.

Investment team

2 current, 0 departed

Contacts

1 general firm email, 2 firm phone

1 general firm email, 2 firm phone on record, each with its source. Values open with the complete profile.

Funds and LPs

2 vehicles, 0 LPs disclosed

Funds and vehicles

2 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
Biomatics Capital Partners II, L.PFund2019 adv first reportedMature$68.0M
May 14, 2024
64$0
of $300M
May 17, 2018
Biomatics Capital Partners, L.P.Fund2016 form d first saleHarvest$141M
Mar 27, 2026
42$200M
of $200M
Nov 17, 2016

Limited partners

0 LPs, 0 disclosed commitments
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.

Known LPs and allocators

0 relationships across the firm's funds, from public pensions and the allocator graph
No allocator names this firm or its funds in a public disclosure DFX holds.

Relationships across DFX

0 co-investors · on 1 other DFX graph

Co-investors

0 counted from shared deals, for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Across DFX and the capital chainon 1 other DFX graph Show
Across DFX
  • The same institution is held on RIA and Wealth, matched by identifier. See which records
Across the graphs

Biomatics Management Company, LLC is the same institution as 1 record in RIA and Wealth.

RIA and Wealth1

The joined record opens with the product, beside every other relationship on this page.

Checking your plan…

Evidence and history

3 dated events, 66 observations from 3 sources

Timeline

3 dated events
  1. Apr 10, 2019
    Biomatics Capital Partners II, L.P first reported on Form ADV by Biomatics Management Company, LLC (Venture Capital Fund), GAV $7,403,904
    Fund first reported on Form ADVFundsFactBiomatics Capital Partners II, L.PForm ADV
  2. Aug 25, 2016
    Biomatics Management Company, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)
    First SEC adviser filingOrganizationFactForm ADV
  3. Aug 25, 2016
    Biomatics Capital Partners, L.P. first reported on Form ADV by Biomatics Management Company, LLC (Venture Capital Fund), GAV $105,000,000
    Fund first reported on Form ADVFundsFactBiomatics Capital Partners, L.P.Form ADV

Identity and regulatory footprint

Address, phone, Form ADV filing and ownersForm ADV filed Mar 27, 2026 · 1 private fundsShow
Headquarters
Seattle, WAadviserinfo.sec.gov
Office address
unknownadviserinfo.sec.gov
Business phone
unknownadviserinfo.sec.gov
Website
BIOMATICSCAPITAL.COM
SEC adviser type
Exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
Venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
Latest Form ADV
Mar 27, 2026
Private funds reported
1 (1 venture capital funds)adviserinfo.sec.gov
Private fund gross assets, adviser total
$141Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder

Classification history

Every classification this record has carried2 on recordShow
  1. Sep 23, 2026
    Institutional venture firm (confirmed, 95%)
    Venture manager, reported GAV $209M across 2 vehicles
  2. Sep 12, 2026
    Institutional venture firm (confirmed, 95%)
    Venture manager, reported GAV $449M across 2 vehicles

Evidence

66 observations from 3 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
Why admittedVC exemption, VC funds reportedMar 27, 2026FactForm ADV
SEC exemption claimedVenture capital fund adviserMar 27, 2026FactForm ADV
SEC exemption claimedVenture capital fund adviserMay 14, 2024FactForm ADV
SEC adviser typeExempt reporting adviserMar 27, 2026FactForm ADV
SEC adviser typeExempt reporting adviserMar 27, 2026FactForm ADV
SEC adviser typeExempt reporting adviserMay 14, 2024FactForm ADV
First Form ADV filing2016-08-25Mar 27, 2026FactForm ADV
First Form ADV filing2016-08-25May 14, 2024FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-29Sep 30, 2026FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-25Sep 26, 2026FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-23Sep 24, 2026FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-21Sep 23, 2026FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-22Sep 23, 2026FactForm ADV
Adv history loadedadv-hist-1Sep 12, 2026FactForm ADV
Latest Form ADV filing2026-03-27Mar 27, 2026FactForm ADV
Latest Form ADV filing2026-03-27Mar 27, 2026FactForm ADV
Latest Form ADV filing2024-05-14May 14, 2024FactForm ADV
SEC statusERA - ActiveMar 27, 2026FactForm ADV
SEC status effective2016-08-25Mar 27, 2026FactForm ADV
Venture share of reported funds1Mar 27, 2026FactForm ADV
Venture share of reported funds1May 14, 2024FactForm ADV
Business phoneMar 27, 2026FactForm ADV
Business phoneMay 14, 2024FactForm ADV
Contact page urlOct 1, 2026Fact
Contact page urlSep 16, 2026Fact
DescriptionOct 1, 2026Fact
DescriptionSep 16, 2026Fact
DescriptionSep 13, 2026Fact
HeadquartersSeattle, WAMar 27, 2026FactForm ADV
HeadquartersSeattle, WAMay 14, 2024FactForm ADV
Office addressMar 27, 2026FactForm ADV
Office addressMay 14, 2024FactForm ADV
Legal formLimited Liability CompanyMar 27, 2026FactForm ADV
Legal formLimited Liability CompanyMay 14, 2024FactForm ADV
Portfolio pageOct 1, 2026Fact
Portfolio pageSep 16, 2026Fact
Portfolio pageSep 13, 2026Fact
Private funds reported1Mar 27, 2026FactForm ADV
Private funds reported1Mar 27, 2026FactForm ADV
Private funds reported2May 14, 2024FactForm ADV
Private fund gross assets (reported)$141MMar 27, 2026FactForm ADV
Private fund gross assets (reported)$141MMar 27, 2026FactForm ADV
Private fund gross assets (reported)$449MMay 14, 2024FactForm ADV
Schedule a diffsadiff-1Sep 26, 2026FactForm ADV
Stated sectorsHealthcare, biotech, medtech
“sector words on the home page”
Oct 1, 2026Fact
Stated sectorsHealthcare, biotech, medtech
“sector words on the home page”
Sep 16, 2026Fact
Stated sectorsHealthcare, biotech, medtech
“sector words on the home page”
Sep 13, 2026Fact
Venture funds reported1Mar 27, 2026FactForm ADV
Venture funds reported1Mar 27, 2026FactForm ADV
Venture funds reported2May 14, 2024FactForm ADV
WebsiteMar 27, 2026FactForm ADV
WebsiteMay 14, 2024FactForm ADV
Site titleOct 1, 2026Fact
Site titleSep 16, 2026Fact
Site titleSep 13, 2026Fact
How this is scored
Scores, classification basis and filing advisersInstitutional venture firm, confirmedShow
Importance
18
moderate
Active deployment
0
low
Emerging
0
low
Freshness
100
high
Institutional venture firmSEC exempt reporting adviser

Venture manager, reported GAV $209M across 2 vehicles

The inputs behind each score
importance
gav: 0.4 · funds: 0.17 · people: 0.08 · investments: 0 · co investors: 0
active deployment
investments 12m: 0 · fund raising 18m: 0 · people joined 12m: 0 · vintage within 3y: 0 · latest investment at: not scored
emerging manager
fund count: 2 · reported gav: $209M · first adv filing: 2016-08-25 · years since first filing: 10.1

Fits, record history and connections

scored matches for this investor, every identity change, every edge

Record history

1 dated event on the change ledger, latest event first
  • Adviser's first ADV filing
    2016-08-25source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.

Not yet on record: new companies, 12 mo.